NOX4 and hepatocellular carcinoma: Dual inhibition of NOX1 and NOX4 with setanaxib (GKT-831) has been shown to result in increased cell cytotoxicity by induction of apoptosis in HCC cell lines, thus identifying a compound with antitumorigenic properties which deserves further evaluation [98].